SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-23-032191
Filing Date
2023-11-15
Accepted
2023-11-15 17:03:55
Documents
1
Period of Report
2023-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 3620
  Complete submission text file 0001437749-23-032191.txt   5064
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VANTAGE CONSULTING GROUP, INC. 3500 PACIFIC AVENUE VIRGINIA BEACH VA 23451
Business Address
Finn Jonathan (Reporting) CIK: 0001981595 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35610 | Film No.: 231411408